News
The UK is studying cases of pancreatitis in people taking drugs based on GLP-1 receptor agonists for weight loss or type 2 ...
Mounjaro is one of the bestselling weight loss drugs. See what your options are if you want to invest in Mounjaro stock.
There are growing concerns about the side effects caused by weight loss injections such as Ozempic, Wegovy and Mounjaro.
U.K. regulators have launched a study into a possible genetic link between use of GLP-1s, such as Ozempic, Mounjaro and Wegovy, and acute pancreatitis. Yellow Card Biobank, a joint initiative of ...
A study has been launched into the side effects of weight-loss jabs after ten people have died and hundreds contracted ...
Weight loss drugs are exploding in popularity across the country with many calling them game-changers when it comes to treating obesity and all the medical cond ...
Viking begins phase III VANQUISH program for VK2735, targeting weight loss in obese adults with or without type II diabetes.
Altimmune shares cratered more than 50% on Thursday after its experimental obesity drug did not significantly improve liver ...
2h
LancsLive on MSNHundreds report complications linked to popular weight loss jabsHundreds of people have reported health complications linked to the use of popular weight loss jabs. The users of the jabs ...
Employers who fail to account for these experiences risk missing a critical part of the employee wellness equation.
Eli Lilly bets on next-generation obesity candidates like orforglipron and retatrutide to sustain growth amid rising ...
Novo Nordisk shares have come under pressure amid weight-loss drug competition, while UK health officials have launched a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results